{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:38:04Z","timestamp":1760297884700},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s11897-007-0011-8","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T16:11:12Z","timestamp":1196957472000},"page":"183-189","source":"Crossref","is-referenced-by-count":8,"title":["Optimizing care of heart failure after acute MI with an aldosterone receptor antagonist"],"prefix":"10.1007","volume":"4","author":[{"given":"Anil","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,5]]},"reference":[{"key":"11_CR1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.0000134791.68010.FA","volume":"110","author":"E.M. Antman","year":"2004","unstructured":"Antman EM, Anbe DT, Armstrong PW, et al.: ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004, 110:588\u2013636.","journal-title":"Circulation"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.100.20.2054","volume":"100","author":"U.C. Guidry","year":"1999","unstructured":"Guidry UC, Evans JC, Larson MG, et al.: Temporal trends in event rates after Q-wave myocardial infarction: the Framingham Heart Study. Circulation 1999, 100:2054\u20132059.","journal-title":"Circulation"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/01.CIR.54.6.849","volume":"54","author":"E. Haber","year":"1976","unstructured":"Haber E: George C. Griffith lecture. The role of renin in normal and pathological cardiovascular homeostasis. Circulation 1976, 54;849\u2013861.","journal-title":"Circulation"},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B. Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999, 341:709\u2013717.","journal-title":"N Engl J Med"},{"key":"11_CR5","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B. Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, et al.; Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003, 348:1309\u20131321. [Published correction appears in N Engl J Med 2003, 348:2271.]","journal-title":"N Engl J Med"},{"key":"11_CR6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3317\/jraas.2000.058","volume":"1","author":"K.T. Weber","year":"2000","unstructured":"Weber KT, Sun Y: Recruitable ACE and tissue repair in the infarcted heart. J Renin Angiotensin Aldosterone Syst 2000, 1:295\u2013303.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"Suppl1","key":"11_CR7","first-page":"107","volume":"88","author":"K.T. Weber","year":"1993","unstructured":"Weber KT, Brilla CG, Campbell SE, et al.: Myocardial fibrosis: role of angiotensin II and aldosterone. Basic Res Cardiol 1993, 88(Suppl 1)107\u2013124.","journal-title":"Basic Res Cardiol"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.553370","volume":"112","author":"S.A. Hunt","year":"2005","unstructured":"Hunt SA, Abraham WT, Chin MH, et al.: ACC\/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112:e154\u2013e235.","journal-title":"Circulation"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","volume":"26","author":"K. Swedberg","year":"2005","unstructured":"Swedberg K, Cleland J, Dargie H, et al.: Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J 2005, 26:1115\u20131140.","journal-title":"Eur Heart J"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/hrt.2003.025312","volume":"90","author":"A.D. Struthers","year":"2004","unstructured":"Struthers AD: Aldosterone blockade in cardiovascular disease. Heart 2004, 90:1229\u20131234.","journal-title":"Heart"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.yjmcc.2005.05.002","volume":"39","author":"A. Lal","year":"2005","unstructured":"Lal A, Veinot JP, Ganten D, Leenen FH: Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen. J Mol Cell Cardiol 2005, 39:521\u2013529.","journal-title":"J Mol Cell Cardiol"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(06)68074-4","volume":"367","author":"L.H. Opie","year":"2006","unstructured":"Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA: Controversies in ventricular remodelling. Lancet 2006, 367:356\u2013367.","journal-title":"Lancet"},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1046\/j.1523-1755.2000.00973.x","volume":"57","author":"C. Delcayre","year":"2000","unstructured":"Delcayre C, Silvestre JS, Garnier A, et al.: Cardiac aldosterone production and ventricular remodeling. Kidney Int 2000, 57:1346\u20131351.","journal-title":"Kidney Int"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.99.20.2694","volume":"99","author":"J.S. Silvestre","year":"1999","unstructured":"Silvestre JS, Heymes C, Oubenaissa A, et al.: Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 1999, 99:2694\u20132701.","journal-title":"Circulation"},{"key":"11_CR15","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0735-1097(01)01539-X","volume":"38","author":"M. Hayashi","year":"2001","unstructured":"Hayashi M, Tsutamoto T, Wada A, et al.: Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 2001, 38:1375\u20131382.","journal-title":"J Am Coll Cardiol"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","volume":"107","author":"S. Hein","year":"2003","unstructured":"Hein S, Arnon E, Kostin S, et al.: Progression from compensated hypertrophy to failure in the pressure-overloaded human heart. Structural deterioration and compensatory mechanisms. Circulation 2003, 107:984\u2013991.","journal-title":"Circulation"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1067\/mhj.2001.111258","volume":"141","author":"M.G. Modena","year":"2001","unstructured":"Modena MG, Aventa P, Menozzi PM, Rossi R: Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction. Am Heart J 2001, 141:41\u201346.","journal-title":"Am Heart J"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/01.CIR.101.13.1527","volume":"101","author":"S.H. Poulsen","year":"2000","unstructured":"Poulsen SH, Host NB, Jensen SE, Egstrup K: Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction. Circulation 2000, 101:1527\u20131532.","journal-title":"Circulation"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","volume":"102","author":"F. Zannad","year":"2000","unstructured":"Zannad F, Alla F, Dousset B, et al.: Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure. Circulation 2000, 102:2700\u20132706.","journal-title":"Circulation"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1161\/01.CIR.0000163562.82134.8E","volume":"111","author":"J. Katada","year":"2005","unstructured":"Katada J, Meguro T, Saito H, et al.: Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptorknockout mice after myocardial infarction. Circulation 2005, 111:2157\u20132164.","journal-title":"Circulation"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1677\/joe.0.0910457","volume":"91","author":"J. Staessen","year":"1981","unstructured":"Staessen J, Lijnen P, Fagard R, et al.: Rise in plasma concentration of aldosterone during long-term angiotensin II suppression. J Endocrinol 1981, 91:457\u2013465.","journal-title":"J Endocrinol"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/j.1552-4604.1993.tb03901.x","volume":"33","author":"C. Borghi","year":"1993","unstructured":"Borghi C, Boschi S, Ambrosioni E, et al.: Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors. J Clin Pharmacol 1993, 33:40\u201345.","journal-title":"J Clin Pharmacol"},{"key":"11_CR23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0735-1097(01)01714-4","volume":"39","author":"W.H. Tang","year":"2002","unstructured":"Tang WH, Vagelos RH, Yee YG, et al.: Neurohormonal and clinical responses to high-versus low-dose enalapril therapy in chronic heart failure. J Am Coll Cardiol 2002, 39:70\u201378. [Published correction appears in J Am Coll Cardiol 2002, 39:746].","journal-title":"J Am Coll Cardiol"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.4065\/80.12.1623","volume":"80","author":"W.H. Tang","year":"2005","unstructured":"Tang WH, Parameswaran AC, Maroo AP, Francis GS: Aldosterone receptor antagonists in the medical management of chronic heart failure. Mayo Clin Proc 2005, 80:1623\u20131630.","journal-title":"Mayo Clin Proc"},{"key":"11_CR25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0735-1097(01)01729-6","volume":"39","author":"J. Bauersachs","year":"2002","unstructured":"Bauersachs J, Heck M, Fraccarollo D, et al.: Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression. J Am Coll Cardiol 2002, 39:351\u2013358.","journal-title":"J Am Coll Cardiol"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","volume":"101","author":"C.A. Farquharson","year":"2000","unstructured":"Farquharson CA, Struthers AD: Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure. Circulation 2000, 101:594\u2013597.","journal-title":"Circulation"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9149(99)80353-1","volume":"76","author":"C.S. Barr","year":"1995","unstructured":"Barr CS, Lang CC, Hanson J, et al.: Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1995, 76:1259\u20131265.","journal-title":"Am J Cardiol"},{"key":"11_CR28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF00542411","volume":"30","author":"T. Dyckner","year":"1986","unstructured":"Dyckner T, Wester PO, Widman L: Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and\/or arterial hypertension. Eur J Clin Pharmacol 1986, 30:535\u2013540.","journal-title":"Eur J Clin Pharmacol"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.106.670109","volume":"115","author":"B. Pitt","year":"2007","unstructured":"Pitt B, Pitt GS: Added benefit of mineralocorticoid receptor blockade in the primary prevention of sudden cardiac death. Circulation 2007, 115:2976\u20132982.","journal-title":"Circulation"},{"issue":"Suppl","key":"11_CR30","doi-asserted-by":"crossref","first-page":"4F","DOI":"10.1016\/j.amjcard.2006.03.004","volume":"97","author":"J.N. Cohn","year":"2006","unstructured":"Cohn JN, Colucci W: Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology. Am J Cardiol 2006, 97(Suppl):4F\u201312F.","journal-title":"Am J Cardiol"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacc.2005.04.038","volume":"46","author":"B. Pitt","year":"2005","unstructured":"Pitt B, White H, Nicolau J, et al.: Eplerenone reduces mortality 30 days postrandomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. J Am Coll Cardiol 2005, 46:425\u2013431.","journal-title":"J Am Coll Cardiol"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1056\/NEJMoa043938","volume":"352","author":"S.D. Solomon","year":"2005","unstructured":"Solomon SD, Zelenkofske S, McMurray JJV, et al.: Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure or both. N Engl J Med 2005, 352:2581\u20132588.","journal-title":"N Engl J Med"},{"issue":"6Suppl","key":"11_CR33","first-page":"S156","volume":"11","author":"J. Banas","year":"2005","unstructured":"Banas J, White H, Parkhomenko A, et al.: Favorable outcomes with 25 mg of eplerenone in patients with post-AMI heart failure: results from the EPHESUS trial. J Card Fail 2005, 11(6 Suppl):S156.","journal-title":"J Card Fail"},{"key":"11_CR34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/clc.4960291004","volume":"29","author":"B. Pitt","year":"2006","unstructured":"Pitt B, Ferrari R, Gheorghiade M, et al.: Aldosterone blockade in post-acute myocardial infarction heart failure. Clin Cardiol 2006, 29:434\u2013438.","journal-title":"Clin Cardiol"},{"key":"11_CR35","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.CIR.0000157146.86758.BC","volume":"111","author":"W.S. Weintraub","year":"2005","unstructured":"Weintraub WS, Zhang Z, Mahoney EM, et al.: Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure. Circulation 2005, 111:1106\u20131113.","journal-title":"Circulation"},{"key":"11_CR36","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","volume":"351","author":"S.H. Hohnloser","year":"2004","unstructured":"Hohnloser SH, Kuck KH, Dorian P, et al.: Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004, 351:2481\u20132488.","journal-title":"N Engl J Med"},{"key":"11_CR37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","volume":"351","author":"D.N. Juurlink","year":"2004","unstructured":"Juurlink DN, Mamdani MM, Lee DS, et al.: Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004, 351:543\u2013551.","journal-title":"N Engl J Med"},{"key":"11_CR38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"A.S. Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, et al.: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999, 130:461\u2013447.","journal-title":"Ann Intern Med"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-007-0011-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11897-007-0011-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-007-0011-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:09:48Z","timestamp":1559434188000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11897-007-0011-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s11897-007-0011-8","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}